SCHEMBL30517871

SCHEMBL30517871

ClCc1cc(Cl)nc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MAOA P21397 2/20 0.50
MAOB P27338 1/20 0.50
KDM4E B2RXH2 4/20 0.47
HTT P42858 2/20 0.46
USP2 O75604 1/20 0.46
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
IGF1R P08069 1/20 0.42
HPGD P15428 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
GAA P10253 2/20 0.41
CYP1A2 P05177 2/20 0.41
MEN1 O00255 1/20 0.41
CYP2D6 P10635 1/20 0.41
POLB P06746 1/20 0.41
HIF1A Q16665 1/20 0.41
TDP1 Q9NUW8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11343689 1.00 KMT2A (0.53) KMT2AMAOAMAOBKDM4EHTT
Hydrochloric Acid SCHEMBL6629225 0.98 KMT2A (0.52) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL3972718 0.86 KDM4E (0.50) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL5910669 0.84 KDM4E (0.53) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL10142233 0.84 MAOA (0.47) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL1240101 0.84 LOXL2 (0.48) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL14177281 0.84 MAOA (0.47) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL832390 0.84 MAOA (0.47) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL3972714 0.84 KDM4E (0.49) KMT2AMAOAMAOBKDM4EHTT
SCHEMBL3294354 0.82 KMT2A (0.50) KMT2AMAOAMAOBKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4476222-A1 FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2024-12-18 EP disclosed
WO-2023154197-A1 FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-08-17 WO disclosed